Current Report Filing (8-k)
May 07 2019 - 3:14PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 7, 2019
CORINDUS
VASCULAR ROBOTICS, INC.
|
(Exact
Name of Registrant as Specified in its Charter)
Delaware
|
|
001-37406
|
|
30-0687898
|
(State
or Other
Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
309
Waverley Oaks Road, Suite 105
Waltham,
MA 02452
|
(Address
of Principal Executive Office) (Zip Code)
|
Registrant’s
telephone number, including area code:
(508) 653-3335
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name
of each exchange on which registered
|
Common
Stock
|
CVRS
|
NYSE
American
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230-405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02.
|
Results of Operations
and Financial Condition.
|
On
May 7, 2019, Corindus Vascular Robotics, Inc. (the “Company”) issued a press release announcing financial results
for the first quarter ended March 31, 2019. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference.
The
information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 2.02 and shall not be
deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report shall
not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made
before or after the date of this Current Report, regardless of any general incorporation language in the filing.
We
do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any
change in events, conditions, or circumstances on which any forward-looking statement is based.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit
Number
|
|
Description
|
|
|
|
|
99.1
|
|
Press
Release of Corindus Vascular Robotics, Inc. dated May 7, 2019 announcing financial results for the first quarter ended March
31, 2019.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
Date: May 7, 2019
|
CORINDUS VASCULAR ROBOTICS, INC.
|
|
|
|
|
By:
|
/s/
David
W. Long
|
|
|
David W. Long
|
|
|
Chief Financial Officer
|
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Corindus Vascular Robotics Inc (American Stock Exchange): 0 recent articles
More Corindus Vascular Robotics, Inc. News Articles